Albireo Pharma Inc Schwankungsanfälligkeit
Was ist das Schwankungsanfälligkeit von Albireo Pharma Inc?
Schwankungsanfälligkeit von Albireo Pharma Inc ist 1.53%
Was ist die Definition von Schwankungsanfälligkeit?
Die Schwankungsanfälligkeit oder Prozent des durchschnittlichen wahren Bereichs (ATRP 14) ist die ATR, ausgedrückt als Prozentsatz des Schlusskurses.
Average true range percent (ATRP) measures volatility on a relative level. This is opposed to the ATR, which measures volatility on an absolute level. ATRP allows securities to be compared whereas ATR does not. That means lower-priced stocks won't necessarily have lower ATR values than higher-priced stocks.
The period used in the calculation is 14 days and the normalized indicator oscillates between 0 and 100 percent of recent price variation. Importantly, the indicator doesn't predict the direction of price but it describes the current volatility. The volatility is comparable across all securities and all markets.
Volatility expresses the degree of price movement. The use of ATRP as volatility compared to ATR is preferred in cases when different securities or different time periods are compared. Examples are stock screening, filtering strategies, and studying seasonality and volatility patterns over long periods of time and different markets
Schwankungsanfälligkeit von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Albireo Pharma Inc
Was macht Albireo Pharma Inc?
Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.
Unternehmen mit schwankungsanfälligkeit ähnlich Albireo Pharma Inc
- 167 hat Schwankungsanfälligkeit von 1.52%
- Csop Asset Management - CSOP Gold Futures Daily (2x) Leveraged Product ETF hat Schwankungsanfälligkeit von 1.52%
- Sprott Physical Silver Trust Us hat Schwankungsanfälligkeit von 1.52%
- Cantel Medical Corp hat Schwankungsanfälligkeit von 1.52%
- GenMark Diagnostics Inc hat Schwankungsanfälligkeit von 1.52%
- iShares Asia Trust - iShares NASDAQ 100 Index ETF hat Schwankungsanfälligkeit von 1.52%
- Albireo Pharma Inc hat Schwankungsanfälligkeit von 1.53%
- NRJ SA hat Schwankungsanfälligkeit von 1.54%
- Cap Gemini S.A hat Schwankungsanfälligkeit von 1.54%
- Million Stars hat Schwankungsanfälligkeit von 1.54%
- Rafaella Resources hat Schwankungsanfälligkeit von 1.54%
- Nestlé SA hat Schwankungsanfälligkeit von 1.54%
- Navy Resources hat Schwankungsanfälligkeit von 1.54%